Optimized ablation strategy for persistent atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a new way to perform ablation (a type of heart procedure) for people with persistent atrial fibrillation (AF) that hasn't responded well to medication. The goal is to see if a targeted approach to the left atrium's back wall works better than standard ablation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are having your first ablation procedure for persistent atrial fibrillation.
- Your atrial fibrillation episodes last between 7 days and 3 years (and symptoms bother you).
- You have tried at least one heart rhythm medication that didn't help enough or caused side effects.
- You do not have long-standing persistent AF (more than 3 years) or certain other heart conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new method to treat persistent atrial fibrillation (a long-lasting irregular heartbeat) to see if it helps patients who haven't been helped by medication. It focuses on cleaning up the back wall of the heart to restore a normal rhythm.
This trial tests whether adding extra ablation lines to the standard pulmonary vein isolation procedure is more effective for people with persistent atrial fibrillation that hasn't been helped by medications. The goal is to improve symptoms like palpitations, fatigue, and shortness of breath.
This trial tests a newer, possibly safer way to treat persistent atrial fibrillation using pulsed field ablation. It compares standard vein isolation alone to adding extra ablation spots to improve success.
This study tests a new way to treat persistent atrial fibrillation using short bursts of electricity (pulsed fields) to carefully reset the heart's rhythm. It may help people whose irregular heartbeat has not improved with medication.
This trial tests whether blocking faulty heart signals from the pulmonary veins (with or without additional “substrate” modification) works better when electric cardioversion doesn’t stop persistent atrial fibrillation. It may help people who remain in atrial fibrillation after cardioversion by reducing symptoms and abnormal rhythm over time.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.